What is the most common organism causing surgical site infections in the hand, particularly in a patient with a history of previous surgical scar, presenting with pain, redness, swelling, and greenish discharge?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Most Common Organism and Discharge Type in Hand Surgical Site Infections

Staphylococcus aureus is the most common organism causing surgical site infections in the hand, and greenish discharge is characteristic of Pseudomonas aeruginosa infection. 1

Primary Causative Organisms

Staphylococcus aureus remains the dominant pathogen in hand infections, accounting for the majority of cases, with methicillin-resistant S. aureus (MRSA) representing an increasingly significant proportion. 1, 2

  • MRSA has become the single most prevalent organism in hand infections, with rates reaching 61% of all hand infections by 2003 in some institutions, and representing 78% of all S. aureus isolates. 2

  • Streptococcus species are the second most common bacterial cause of hand infections. 1

  • In surgical site infections overall, S. aureus accounts for 39.9-45.9% of complicated skin and soft tissue infections, making it the leading pathogen. 3

Discharge Characteristics and Organism Correlation

Greenish discharge is pathognomonic for Pseudomonas aeruginosa infection, which is the second most common organism in complicated skin and soft tissue infections after S. aureus. 3

  • Pseudomonas aeruginosa accounts for 10.8-12.1% of complicated skin and soft tissue infections in surveillance studies. 3

  • Purulent drainage (regardless of color) is diagnostic of surgical site infection and requires prompt drainage. 4

  • The presence of greenish discharge in a patient with previous surgical scar, pain, redness, and swelling strongly suggests Pseudomonas infection requiring specific antibiotic coverage. 3

Clinical Context for This Patient

Given the presentation of greenish discharge with pain, redness, and swelling at a previous surgical site, this represents a surgical site infection most likely caused by Pseudomonas aeruginosa, though polymicrobial infection including S. aureus cannot be excluded. 3

  • Wound cultures should be obtained before initiating antibiotic therapy to guide subsequent treatment. 5

  • The infection requires both surgical drainage and antibiotic therapy covering both gram-positive organisms (including MRSA) and Pseudomonas. 6

Treatment Implications

Empiric antibiotic therapy must cover MRSA and Pseudomonas aeruginosa in this clinical scenario of post-surgical hand infection with greenish discharge. 6, 2

  • Recommended regimen includes vancomycin or linezolid for MRSA coverage plus piperacillin-tazobactam for Pseudomonas coverage. 6

  • Incision and drainage is mandatory as the primary intervention, with antibiotics serving as adjunctive therapy. 3, 5

  • MRSA strains demonstrate 100% sensitivity to linezolid and tigecycline, with vancomycin remaining effective (though 1.12% of strains may show intermediate resistance). 7

Common Pitfalls

  • Failing to recognize that greenish discharge indicates Pseudomonas infection and treating only for gram-positive organisms will result in treatment failure. 3

  • Delaying surgical drainage while relying solely on antibiotics leads to progression of infection and increased morbidity. 5

  • Underestimating the prevalence of MRSA in hand infections (now exceeding 60% in many institutions) and using beta-lactam monotherapy results in inadequate coverage. 2

  • Not obtaining cultures before antibiotic initiation prevents targeted therapy adjustment and antimicrobial stewardship. 5

References

Research

Hand infections.

The Journal of hand surgery, 2011

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Surgical Site Infections: Definition, Epidemiology, and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Surgical Site Infection After Closure of Colostomy for Imperforate Anus

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment for Post-Surgical Skin Infection Unresponsive to Amoxicillin

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Surgical Site Infection by Methicillin Resistant Staphylococcus aureus- on Decline?

Journal of clinical and diagnostic research : JCDR, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.